Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.
Identifieur interne : 006435 ( PubMed/Checkpoint ); précédent : 006434; suivant : 006436Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.
Auteurs : W U Shipley ; G. Kopelson ; D H Novack ; C C Ling ; S P Dretler ; G R ProutSource :
- The Journal of urology [ 0022-5347 ] ; 1980.
Descripteurs français
- KwdFr :
- Curiethérapie (effets indésirables), Dosimétrie en radiothérapie, Dysfonctionnement érectile (étiologie), Essaimage tumoral, Humains, Lymphadénectomie, Mâle, Pelvis, Radio-isotopes de l'iode (effets indésirables), Radio-isotopes de l'iode (usage thérapeutique), Récidive tumorale locale, Soins préopératoires, Troubles mictionnels (étiologie), Tumeurs de la prostate (), Études d'évaluation comme sujet, Études de suivi.
- MESH :
- effets indésirables : Curiethérapie, Radio-isotopes de l'iode.
- usage thérapeutique : Radio-isotopes de l'iode.
- étiologie : Dysfonctionnement érectile, Troubles mictionnels.
- Dosimétrie en radiothérapie, Essaimage tumoral, Humains, Lymphadénectomie, Mâle, Pelvis, Récidive tumorale locale, Soins préopératoires, Tumeurs de la prostate, Études d'évaluation comme sujet, Études de suivi.
English descriptors
- KwdEn :
- Brachytherapy (adverse effects), Erectile Dysfunction (etiology), Evaluation Studies as Topic, Follow-Up Studies, Humans, Iodine Radioisotopes (adverse effects), Iodine Radioisotopes (therapeutic use), Lymph Node Excision, Male, Neoplasm Recurrence, Local, Neoplasm Seeding, Pelvis, Preoperative Care, Prostatic Neoplasms (therapy), Radiotherapy Dosage, Urination Disorders (etiology).
- MESH :
- chemical , adverse effects : Iodine Radioisotopes.
- adverse effects : Brachytherapy.
- etiology : Erectile Dysfunction, Urination Disorders.
- chemical , therapeutic use : Iodine Radioisotopes.
- therapy : Prostatic Neoplasms.
- Evaluation Studies as Topic, Follow-Up Studies, Humans, Lymph Node Excision, Male, Neoplasm Recurrence, Local, Neoplasm Seeding, Pelvis, Preoperative Care, Radiotherapy Dosage.
Abstract
The 30 patients with clinically and surgically localized prostatic carcinoma who were selected for treatment by a short course of preoperative irradiation (1,050 rad), pelvic lymphadenectomy and 125iodine implant have been followed for 1 to 4 years. Perioperative morbidity (10 per cent), postimplant impotence (11 per cent), lymphedema (17 per cent), tumor recurrence (4 per cent) and distant metastasis (4 per cent) have been minimal to date. However, urinary irritative symptoms, which usually subsided in 6 to 9 months, occurred in half of the patients and correlated with implant volume. Total dose and total dose per unit of implanted activity were calculated. Of the various implant parameters evaluated implant dose homogeneity has corrrelated with the rate of tumor regression.
PubMed: 7452792
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:7452792Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.</title><author><name sortKey="Shipley, W U" sort="Shipley, W U" uniqKey="Shipley W" first="W U" last="Shipley">W U Shipley</name></author><author><name sortKey="Kopelson, G" sort="Kopelson, G" uniqKey="Kopelson G" first="G" last="Kopelson">G. Kopelson</name></author><author><name sortKey="Novack, D H" sort="Novack, D H" uniqKey="Novack D" first="D H" last="Novack">D H Novack</name></author><author><name sortKey="Ling, C C" sort="Ling, C C" uniqKey="Ling C" first="C C" last="Ling">C C Ling</name></author><author><name sortKey="Dretler, S P" sort="Dretler, S P" uniqKey="Dretler S" first="S P" last="Dretler">S P Dretler</name></author><author><name sortKey="Prout, G R" sort="Prout, G R" uniqKey="Prout G" first="G R" last="Prout">G R Prout</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1980">1980</date><idno type="RBID">pubmed:7452792</idno><idno type="pmid">7452792</idno><idno type="wicri:Area/PubMed/Corpus">006D65</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006D65</idno><idno type="wicri:Area/PubMed/Curation">006D65</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">006D65</idno><idno type="wicri:Area/PubMed/Checkpoint">006D65</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">006D65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.</title><author><name sortKey="Shipley, W U" sort="Shipley, W U" uniqKey="Shipley W" first="W U" last="Shipley">W U Shipley</name></author><author><name sortKey="Kopelson, G" sort="Kopelson, G" uniqKey="Kopelson G" first="G" last="Kopelson">G. Kopelson</name></author><author><name sortKey="Novack, D H" sort="Novack, D H" uniqKey="Novack D" first="D H" last="Novack">D H Novack</name></author><author><name sortKey="Ling, C C" sort="Ling, C C" uniqKey="Ling C" first="C C" last="Ling">C C Ling</name></author><author><name sortKey="Dretler, S P" sort="Dretler, S P" uniqKey="Dretler S" first="S P" last="Dretler">S P Dretler</name></author><author><name sortKey="Prout, G R" sort="Prout, G R" uniqKey="Prout G" first="G R" last="Prout">G R Prout</name></author></analytic><series><title level="j">The Journal of urology</title><idno type="ISSN">0022-5347</idno><imprint><date when="1980" type="published">1980</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brachytherapy (adverse effects)</term><term>Erectile Dysfunction (etiology)</term><term>Evaluation Studies as Topic</term><term>Follow-Up Studies</term><term>Humans</term><term>Iodine Radioisotopes (adverse effects)</term><term>Iodine Radioisotopes (therapeutic use)</term><term>Lymph Node Excision</term><term>Male</term><term>Neoplasm Recurrence, Local</term><term>Neoplasm Seeding</term><term>Pelvis</term><term>Preoperative Care</term><term>Prostatic Neoplasms (therapy)</term><term>Radiotherapy Dosage</term><term>Urination Disorders (etiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Curiethérapie (effets indésirables)</term><term>Dosimétrie en radiothérapie</term><term>Dysfonctionnement érectile (étiologie)</term><term>Essaimage tumoral</term><term>Humains</term><term>Lymphadénectomie</term><term>Mâle</term><term>Pelvis</term><term>Radio-isotopes de l'iode (effets indésirables)</term><term>Radio-isotopes de l'iode (usage thérapeutique)</term><term>Récidive tumorale locale</term><term>Soins préopératoires</term><term>Troubles mictionnels (étiologie)</term><term>Tumeurs de la prostate ()</term><term>Études d'évaluation comme sujet</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Iodine Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Brachytherapy</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Curiethérapie</term><term>Radio-isotopes de l'iode</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erectile Dysfunction</term><term>Urination Disorders</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Iodine Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes de l'iode</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Dysfonctionnement érectile</term><term>Troubles mictionnels</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Evaluation Studies as Topic</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Male</term><term>Neoplasm Recurrence, Local</term><term>Neoplasm Seeding</term><term>Pelvis</term><term>Preoperative Care</term><term>Radiotherapy Dosage</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dosimétrie en radiothérapie</term><term>Essaimage tumoral</term><term>Humains</term><term>Lymphadénectomie</term><term>Mâle</term><term>Pelvis</term><term>Récidive tumorale locale</term><term>Soins préopératoires</term><term>Tumeurs de la prostate</term><term>Études d'évaluation comme sujet</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The 30 patients with clinically and surgically localized prostatic carcinoma who were selected for treatment by a short course of preoperative irradiation (1,050 rad), pelvic lymphadenectomy and 125iodine implant have been followed for 1 to 4 years. Perioperative morbidity (10 per cent), postimplant impotence (11 per cent), lymphedema (17 per cent), tumor recurrence (4 per cent) and distant metastasis (4 per cent) have been minimal to date. However, urinary irritative symptoms, which usually subsided in 6 to 9 months, occurred in half of the patients and correlated with implant volume. Total dose and total dose per unit of implanted activity were calculated. Of the various implant parameters evaluated implant dose homogeneity has corrrelated with the rate of tumor regression.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7452792</PMID><DateCreated><Year>1981</Year><Month>03</Month><Day>17</Day></DateCreated><DateCompleted><Year>1981</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-5347</ISSN><JournalIssue CitedMedium="Print"><Volume>124</Volume><Issue>5</Issue><PubDate><Year>1980</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of urology</Title><ISOAbbreviation>J. Urol.</ISOAbbreviation></Journal><ArticleTitle>Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.</ArticleTitle><Pagination><MedlinePgn>639-42</MedlinePgn></Pagination><Abstract><AbstractText>The 30 patients with clinically and surgically localized prostatic carcinoma who were selected for treatment by a short course of preoperative irradiation (1,050 rad), pelvic lymphadenectomy and 125iodine implant have been followed for 1 to 4 years. Perioperative morbidity (10 per cent), postimplant impotence (11 per cent), lymphedema (17 per cent), tumor recurrence (4 per cent) and distant metastasis (4 per cent) have been minimal to date. However, urinary irritative symptoms, which usually subsided in 6 to 9 months, occurred in half of the patients and correlated with implant volume. Total dose and total dose per unit of implanted activity were calculated. Of the various implant parameters evaluated implant dose homogeneity has corrrelated with the rate of tumor regression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shipley</LastName><ForeName>W U</ForeName><Initials>WU</Initials></Author><Author ValidYN="Y"><LastName>Kopelson</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Novack</LastName><ForeName>D H</ForeName><Initials>DH</Initials></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>C C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Dretler</LastName><ForeName>S P</ForeName><Initials>SP</Initials></Author><Author ValidYN="Y"><LastName>Prout</LastName><ForeName>G R</ForeName><Initials>GR</Initials><Suffix>Jr</Suffix></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Urol</MedlineTA><NlmUniqueID>0376374</NlmUniqueID><ISSNLinking>0022-5347</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007457">Iodine Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001918" MajorTopicYN="Y">Brachytherapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007172" MajorTopicYN="N">Erectile Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005069" MajorTopicYN="N">Evaluation Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007457" MajorTopicYN="N">Iodine Radioisotopes</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="Y">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009366" MajorTopicYN="N">Neoplasm Seeding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014555" MajorTopicYN="N">Urination Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1980</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1980</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">7452792</ArticleId><ArticleId IdType="pii">S0022-5347(17)55593-7</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Dretler, S P" sort="Dretler, S P" uniqKey="Dretler S" first="S P" last="Dretler">S P Dretler</name><name sortKey="Kopelson, G" sort="Kopelson, G" uniqKey="Kopelson G" first="G" last="Kopelson">G. Kopelson</name><name sortKey="Ling, C C" sort="Ling, C C" uniqKey="Ling C" first="C C" last="Ling">C C Ling</name><name sortKey="Novack, D H" sort="Novack, D H" uniqKey="Novack D" first="D H" last="Novack">D H Novack</name><name sortKey="Prout, G R" sort="Prout, G R" uniqKey="Prout G" first="G R" last="Prout">G R Prout</name><name sortKey="Shipley, W U" sort="Shipley, W U" uniqKey="Shipley W" first="W U" last="Shipley">W U Shipley</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006435 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 006435 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:7452792
|texte= Preoperative irradiation, lymphadenectomy and 125iodine implant for patients with localized prostatic carcinoma: a correlation of implant dosimetry with clinical results.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:7452792" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |